FDG-PET/CT Predicts Outcome in Oropharingeal Carcinoma Patients Undergoing Intensity Modulated Radiation Therapy with Dose Escalation to FDG-avid Tumour Volumes

Publisher： Bentham Science Publishers

E-ISSN： 1874-4729|10|2|102-110

ISSN： 1874-4710

Source： Current Radiopharmaceuticals, Vol.10, Iss.2, 2017-08, pp. : 102-110

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Detection of Metastases in Patients with Cutaneous Melanoma Using FDG-PET/CT

By Akcali C   Zincirkeser S   Erbagcý Z   Akcali A   Halac M   Durak G   Sager S   Sahin E  

The Journal of International Medical Research, Vol. 35, Iss. 4, 2007-07 ,pp. : 547-553

Field House Publishing

Access to resources Recommend Favorite

PET/CT Dose Planning for Volumetric Modulated arc Radiation Therapy (VMAT) -Comparison with Conventional Approach in Advanced Prostate Cancer Patients

By  

Current Radiopharmaceuticals, Vol. 8, Iss. 1, 2015-05 ,pp. : 2-8

Bentham Science Publishers

Access to resources Recommend Favorite

18F-FDG-PET/CT in Patients Affected by Differentiated Thyroid Carcinoma with Positive Thyroglobulin Level and Negative 131I Whole Body Scan. It's Value Confirmed by a Bicentric Experience

By  

Current Radiopharmaceuticals, Vol. 9, Iss. 3, 2016-12 ,pp. : 228-234

Bentham Science Publishers

Access to resources Recommend Favorite

Risk stratification in patients with advanced-stage breast cancer by pretreatment [18F]FDG PET/CT

By  

Cancer, Vol. 121, Iss. 22, 2015-11 ,pp. : 3965-3974

Blackwell Publishing

Access to resources Recommend Favorite

FDG‐PET/CT is a pivotal imaging modality to diagnose rare intravascular large B‐cell lymphoma: case report and review of literature

By  

Hematological Oncology (Electronic), Vol. 33, Iss. 2, 2015-06 ,pp. : 99-109

John Wiley & Sons Inc

Access to resources Recommend Favorite